- FTC Requires Divestitures in Connection with Baxter's Purchase of Wyeth's Generic Injectable Drug Business ( )
- FTC Releases Health Care and Competition Law and Policy Workshop Materials ( )
- FTC Chairman Announces Public Hearings on Health Care and Competition Law and Policy to Begin in February 2003 ( )
- Statement of Federal Trade Commission Chairman Timothy Muris on the FDA's Proposals to Improve Consumer Access To Lower-Cost Generic Drugs ( )
- FTC Staff Opposes Ohio Bill To Allow Physician Collective Bargaining ( )
- Announced Actions for October 11, 2002 ( )
- Announced Action for October 4, 2002 ( )
- Announced Action for September 6, 2002 ( )
- Federal Trade Commission Announces Formation of Merger Litigation Task Force ( )
- Denver-Area Physician Practice Groups and Their Agent Agree to Settle FTC Charges of Fixing Fees ( )
- Dallas-Fort Worth-area Physicians Group Agrees to Settle ( )
- Announced Actions for August 20, 2002 ( )
- Resolving Anticompetitive Concerns, FTC Clears $16 Billion Acquisition of Immunex Corp. By Amgen Inc. ( )
- Administrative Law Judge Dismisses FTC Allegations of Anticompetitive Conduct by Schering-plough and Upsher-Smith ( )
- Announced Action for June 4, 2002 ( )
- Two Denver-area Physician Groups Agree To Settle FTC Charges of Fixing Fees ( )
- Wrongful "Orange Book" Listing Raises Red Flag with FTC; Leads to Consent Order with Biovail Corp. Concerning its Drug Tiazac ( )
- Napa Valley OB/GYN Group Settles FTC Antitrust Charges ( )
- FTC Staff Opposes Alaska Physicians' Health Plan Legislation: ( )
- Staff Advisory Opinion: ( )
- FTC Agreement with American Home Products Corp. Would Protect Consumers from Anticompetitive Practices ( )
- FTC Staff Opposes Washington State Proposal to Allow Physician Collective Bargaining ( )
- FTC Staff Opposes Alaska Proposal to Allow Physician Collective Bargaining ( )
- Announced Actions for January 9, 2002 ( )
- Non-profit Institutions Act Covers Pharmaceuticals Dispensed to Retired Employees, FTC Staff Advises ( )
- Hearst Corp. To Disgorge $19 Million and Divest Business to Facts and Comparisons to Settle FTC Complaint ( )
- Statement of Susan A. Creighton, Deputy Director, Bureau of Competition Regarding FTC Settlement with Hearst Corporation ( )
- Announced Actions for April 30, 2001 ( )
- FTC Charges Hearst Trust with Acquiring Monopoly in Vital Drug Information Market ( )
- Consent Agreement Resolves Complaint Against Pharmaceutical Companies Hoechst Marion Roussel, Inc. and Andrx Corp. ( )
The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.
The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.